Shineco (SISI) has entered into a strategic cooperation agreement with Singapore-based BICC to jointly promote the implementation and redemption of “on-chain cell assets” across multiple institutions and scenarios. This collaboration marks a new phase of “cross-enterprise redeemability” for cell assets on the blockchain, advancing the RWA ecosystem from “technical on-chain integration” to “real-world application. This partnership builds on Shineco’s prior initiatives: establishing a Cell Digital Division, signing an agreement with Plus Me Limited for on-chain cell asset management and marketing ecosystems, and acquiring a 51% stake in Xi’an Dong’ao Health Management. The two parties will collaborate on standard-setting, compliance coordination, and scenario exploration to transition the project from “technical feasibility” to “verifiable applicability.”Under the cooperation framework, Plus Me will provide full-lifecycle digital management for Shineco’s compliant mesenchymal stem cells on the Ethereum mainnet, generating”digital identities” and issuing ERC-1400/ERC-20 standard “Cell Reimbursement Vouchers.” Following the collaboration with BICC, BICC’s iPSC stem cell storage services will be integrated into Shineco’s blockchain system. Users holding” Cell Reimbursement Vouchers” will be able to redeem them in designated BICC scenarios, forming a cross-enterprise service
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SISI:
- Shineco Stock (SISI) Rockets 45% on Cellular Blockchain Agreement
- Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
- Target names CEO successor, Guess to go private: Morning Buzz
- Shineco, Plus Me execute cooperation agreement
- Upcoming Stock Splits This Week (August 11 to August 15) – Stay Invested